Age, Biography and Wiki
René Bernards was born on 4 January, 1953 in the Netherlands, is a researcher. Discover René Bernards's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is He in this year and how He spends money? Also learn how He earned most of networth at the age of 70 years old?
| Popular As |
N/A |
| Occupation |
N/A |
| Age |
71 years old |
| Zodiac Sign |
Capricorn |
| Born |
4 January 1953 |
| Birthday |
4 January |
| Birthplace |
N/A |
| Nationality |
The Netherlands |
We recommend you to check the complete list of Famous People born on 4 January.
He is a member of famous researcher with the age 71 years old group.
René Bernards Height, Weight & Measurements
At 71 years old, René Bernards height not available right now. We will update René Bernards's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
| Physical Status |
| Height |
Not Available |
| Weight |
Not Available |
| Body Measurements |
Not Available |
| Eye Color |
Not Available |
| Hair Color |
Not Available |
Dating & Relationship status
He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.
| Family |
| Parents |
Not Available |
| Wife |
Not Available |
| Sibling |
Not Available |
| Children |
Not Available |
René Bernards Net Worth
His net worth has been growing significantly in 2022-2023. So, how much is René Bernards worth at the age of 71 years old? René Bernards’s income source is mostly from being a successful researcher. He is from The Netherlands. We have estimated
René Bernards's net worth
, money, salary, income, and assets.
| Net Worth in 2023 |
$1 Million - $5 Million |
| Salary in 2023 |
Under Review |
| Net Worth in 2022 |
Pending |
| Salary in 2022 |
Under Review |
| House |
Not Available |
| Cars |
Not Available |
| Source of Income |
researcher |
René Bernards Social Network
| Instagram |
|
| Linkedin |
|
| Twitter |
|
| Facebook |
|
| Wikipedia |
|
| Imdb |
|
Timeline
In 2012 Bernards won the Koningin Wilhelmina Onderzoeksprijs by the Dutch Cancer Society, earning a 2 million euro subsidy. In 2013 he was named as recipient of the Royal Netherlands Academy of Arts and Sciences Academy Professor Prize, together with Wil Roebroeks. Bernards was elected a Fellow of the American Association for Cancer Research Academy in 2018. In 2019 he became an international honorary member of the American Academy of Arts and Sciences. In 2020 he was elected an international member of the National Academy of Sciences of the United States.
In 2003 he was co-founder of the biotechnology company Agendia, where he works as Chief Scientific Officer.
Bernards was elected a member of the European Molecular Biology Organization in 1995. Bernards was a winner of the Spinoza Prize in 2005. The awarding organisation, the Netherlands Organisation for Scientific Research, specified his "groundbreaking work in the molecular biology and diagnostics of cancer". In 2005 he was also elected a member of Academia Europaea. Bernards was elected a member of the Royal Netherlands Academy of Arts and Sciences in 2007.
From 1988 to 1992 Bernards was an assistant professor at Harvard Medical School. He returned to the Netherlands in 1992 and became head of the section of molecular carcinogenesis at the Netherlands Cancer Institute-Antoni van Leeuwenhoekziekenhuis. Bernards was named part-time professor of molecular carcinogenesis at Utrecht University in 1994.
René Bernards (born 4 January 1953) is a Dutch cancer researcher. He is professor of molecular carcinogenesis at Utrecht University and head of the section of molecular carcinogenesis at the Netherlands Cancer Institute-Antoni van Leeuwenhoekziekenhuis. Bernards is a winner of the 2005 Spinoza Prize.
Bernards was born in Bussum on 4 January 1953. He studied medical biology at the University of Amsterdam. Bernards subsequently obtained his PhD from Leiden University in 1984 under A.J. van der Eb with a thesis titled: Transformation and oncogenicity by human adenoviruses. He then moved to the United States and was a post doc under Robert Weinberg at the Whitehead Institute.
